FDA-Cleared Digital Pathology Platform
Empowering Pathologists in Diagnosis
HALO AP Dx is FDA cleared for primary diagnosis
State-of-the-Art Anatomic Pathology Software
HALO AP Dx is a case-centric pathology platform that enables primary diagnosis, remote working, and other routine workflows in anatomic pathology. For primary diagnostic applications, HALO AP Dx is FDA-cleared in the US, while HALO AP® is CE-IVDR marked in the EU, Switzerland, and the UK. Learn from a practicing pathologist how HALO AP improved patient care in their lab.
Faster Diagnoses
Increase the efficiency of your diagnoses without compromising on accuracy. The case-centric HALO AP Dx platform enables slides to be reviewed from any location the moment they are scanned, allowing pathologists to diagnose cases remotely without waiting on the physical transfer of slides.
Collaborate with Colleagues Near and Far
With just a few clicks you can send out cases for a second opinion, resulting in improved patient care, reduced turnaround times, and eliminated shipping costs.
HALO AP Dx enables pathologists to expand their reach by receiving inbound digital consults.
Customized and Secure Deployments
HALO AP Dx offers on-premise and cloud-based deployments that work within your IT framework. With enterprise-grade administration, you can easily scale the number of users as your lab grows.
Our Cloud Services division helps organizations migrate to, manage, and optimize their cloud deployments, delivering a highly performant, flexible, and secure environment. You can count on our AWS Certified Solution Architects, Technical Solutions team, and our knowledgeable applications support.
HALO AP Dx Integrates into Existing Laboratory Frameworks
Step 1
Step 2
Step 3
Step 4
Step 5
Step 6
HALO AP Dx works with your laboratory information or laboratory information management system (LIS | LIMS) instead of replacing it. Access the right data at the right time by integrating with your LIS | LIMS, eliminating the need to move between platforms. Open, API-first technology supports bi-directional connectivity to any application.
True Interoperability
HALO AP is compatible with files from all major scanners and our staff are well-versed in data migration, with expertise integrating many common LIS | LIMS systems in enterprise-wide deployments.
Conducting research? Feed your pipeline using the option to export deidentified cases and manage the images with the HALO Link collaborative image management system or another IMS.
Interested in learning more?
Schedule a call to see how HALO AP Dx can meet your needs.
Comprehensive Integration, Training, and Support Services
Platform Compatibility
HALO AP Dx is approved for use with the Hamamatsu NanoZoomer® S360MD Slide scanner and JVC JD-C240BN01A display. Please email us for information on existing LIS | LIMS integrations.
FDA-Cleared File Format:
- Hamamatsu (NDPI)
Research Use Only File Formats:
- Non-proprietary (JPG, TIF, OME.TIFF, DICOM [DCM*])
- Leica (SVS, AFI, SCN, LIF)
- Hamamatsu (NDPI, NDPIS)
- Philips (iSyntax, i2Syntax)
- 3DHistech (MRXS)
- Nikon (ND2)
- Akoya (QPTIFF, component TIFF)
- Olympus / Evident (VSI)
- Zeiss (CZI)
- Ventana (BIF)
- KFBIO (KFB, KFBF)
*whole-slide images
Devices:
- Windows PC
- Macintosh
Browsers:
- Chrome
- Microsoft Edge
Looking to incorporate AI and image analysis?
Learn about our HALO AP® platform that seamlessly integrates image analysis, AI, and third-party AI in a CE-IVDR marked platform.
Features of HALO AP Dx
Modernize tumor board preparation by quickly assigning cases, slides, and clinically relevant regions with notes. Instantly recall and navigate regions of interest with a single click and quickly add any case notes.
HALO AP Dx streamlines clinical trials across multiple hospitals and CROs by enabling coordinators to create, manage, and monitor trials from a single interface. The blind scoring feature simplifies blinded workflows, making clinical trials and research studies easier to conduct. Results can be easily exported for downstream analysis.
What Our Customers Have to Say
HALO AP Dx is a newly launched product. Click here to read reviews for our CE-IVDR marked HALO AP platform.
Knowledge Center
Learn more about HALO AP Dx by exploring the tabs below.
HALO AP® and HALO AP Dx Brochure
Download our brochure to learn more about how HALO AP Dx brings AI-powered digital pathology to labs across the globe.
Submit the form below to view the requested document
Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner
Albuquerque, NM, and Hamamatsu City, Japan – 22 May, 2024 – Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K.,
Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform
Albuquerque, NM – 8 May 2024 – Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA clearance for HALO
HALO AP® and HALO AP Dx: Pathologist-Centric Enterprise Digital Pathology Platforms
10 October 2024 | Join us for this 1-hour webinar to learn about HALO AP platforms with regulatory clearances supporting diagnostic workflows in the US
Introducing HALO AP Dx: An Enterprise Pathology Platform for Primary Diagnosis
13 June 2024 | Join us for this 1-hour webinar to see a live demonstration of HALO AP Dx, the 510k-cleared digital pathology platform from
Enhancing Patient Care with Seamless Clinical Collaboration: Streamlining Tumor Boards and MDTs with the Tumor Board Functionality of HALO AP® and HALO AP Dx
With the HALO AP platforms and their dedicated Tumor Board functionalities, pathologists can enhance multidisciplinary communication and improve treatment planning.
News & Events
Enhancing Patient Care with Seamless Clinical Collaboration: Streamlining Tumor Boards and MDTs with the Tumor Board Functionality of HALO AP® and HALO AP Dx
With the HALO AP platforms and their dedicated Tumor Board functionalities, pathologists can enhance multidisciplinary communication and improve treatment planning.
HALO AP® and HALO AP Dx: Pathologist-Centric Enterprise Digital Pathology Platforms
10 October 2024 | Join us for this 1-hour webinar to learn about HALO AP platforms with regulatory clearances supporting diagnostic workflows in the US
Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform
Albuquerque, NM – 2 July 2024 – Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
Regulatory Compliance
HALO AP Dx (K232833) is FDA-cleared for primary diagnostic use with the Hamamatsu NanoZoomer® S360MD Slide scanner in the USA. In addition, HALO AP Dx provides built-in compliance with FDA 21 CFR Part 11 and HIPAA.
HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR.
Deploy HALO AP Dx in a Fully Managed Cloud-Hosted Environment
In addition to on premises deployments, Indica Labs offers optimized deployments of HALO AP Dx software hosted in Amazon Web Services (AWS). We manage all aspects of implementation and ongoing maintenance to provide a highly performant, scalable, and secure environment in the cloud. You maintain full ownership over your AWS account while our AWS Certified Solutions Architects manage your infrastructure and HALO AP Dx software environments.
Learn more about the benefits of cloud-hosted environments in our recent blog post or reach out today to our Cloud Services team by using the form below and learn whether a managed cloud deployment is right for you.
Want to Learn More?
Fill out the form below to request a recorded or live demo of HALO AP Dx or any of our other products or services.
You can also drop us an email at info@indicalab.com